Mandate

Vinge advises Baseload Capital in connection with its 53 MEUR Series B financing round

September 04, 2024

Vinge has advised Baseload Capital Holding AB in connection with the closing of its 53 MEUR Series B financing round. The round was led by an investment from infrastructure fund ENGF. The main investor behind ENGF is Ingka Investments, the investment arm of Ingka Group. Other shareholders participating in this round include energy technology company Baker Hughes (whose investment was announced in 2023), NEFCO, Breakthrough Energy Ventures and Gullspång Invest.

Baseload Capital is a leading investment entity dedicated to advancing geothermal energy deployment globally. Through the establishment of operating companies in global locations, Baseload Capital partners with local communities and power providers to commission, permit and build Baseload Capital-funded geothermal power plants. Baseload Capital and its Baseload Power subsidiaries operate in mature geothermal markets like Iceland, the US, and Japan, as well as in emerging markets like Taiwan. As one of the first European investments by Breakthrough Energy Ventures (BEV), Baseload Capital also carries a certain quality mark as BEV only invests in companies that can reduce emissions by at least half a gigaton of greenhouse gases. 

Vinges team consisted primarily of Maria Dahlin Kolvik, Gustav Wahlberg and Måns Håkansson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025